QT
KERX

Quantbot Technologies’s Keryx Biopharmaceuticals Inc KERX Stock Holding History

Quantbot Technologies’s Portfolio KERX Stock Details KERX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-12,796
Closed -$127K – 1561
2015
Q2 		$127K Buy
12,796
+293
+2% +$3.14K 0.02% 578
2015
Q1 		$159K Sell
12,503
-4,605
-27% -$59.2K 0.04% 476
2014
Q4 		$242K Sell
17,108
-39,073
-70% -$605K 0.08% 367
2014
Q3 		$772K Buy
56,181
+32,108
+133% +$492K 0.11% 293
2014
Q2 		$370K Buy
+24,073
New +$341K 0.06% 410

Other funds holding KERX

BG
Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
ACM
Abrams Capital Management Boston, Massachusetts $4.64B AUM 1.52% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
ORI
Oak Ridge Investments Chicago, Illinois $1.77B AUM 63.16% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
ACM
Apex Capital Management Dayton, Ohio $4.54B AUM 1.74% 1-Year Est. Return

Quantbot Technologies's KERX Position: Q3 2015 in Review

Quantbot Technologies sold out of Keryx Biopharmaceuticals Inc (KERX) in Q3 2015, closing a stake of 12,796 shares — an estimated $127K sold.

Quantbot Technologies first reported a position in KERX in Q2 2014 and held it in 5 quarters. The position peaked at $772K in Q3 2014. 138 funds tracked by Wall St. Rank hold KERX as of Q3 2015.

  • Quantbot Technologies reported no remaining Keryx Biopharmaceuticals Inc position as of Q3 2015 after selling out during the quarter.
  • Quantbot Technologies sold 12,796 Keryx Biopharmaceuticals Inc shares in Q3 2015, an estimated $127K.
  • Quantbot Technologies first reported a position in Keryx Biopharmaceuticals Inc in Q2 2014 and held it in 5 quarters.
  • Quantbot Technologies's Keryx Biopharmaceuticals Inc position peaked at $772K in Q3 2014.
  • 138 funds tracked by Wall St. Rank held Keryx Biopharmaceuticals Inc as of Q3 2015.

Based on Quantbot Technologies's 13F filing for Q3 2015, filed 22 Oct 2015.